CellaVision AB (publ) (OTCMKTS:CLVSF) Short Interest Up 400.0% in February

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 500 shares, an increase of 400.0% from the February 13th total of 100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 5.0 days.

CellaVision AB (publ) Price Performance

Shares of CLVSF stock remained flat at $19.28 on Wednesday. The stock’s 50-day moving average price is $19.48 and its 200-day moving average price is $22.88. CellaVision AB has a twelve month low of $19.28 and a twelve month high of $19.91.

CellaVision AB (publ) Company Profile

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.